Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway

British Journal of Cancer, Published online: 05 February 2024; doi:10.1038/s41416-024-02599-6Approval of DFMO for high-risk neuroblastoma patients demonstrates a step of success to target MYC pathway

Source: British Journal of Cancer - February 5, 2024 Category: Cancer & Oncology Authors: Jun Yang Source Type: research